The United States Food and Drug Administration (USFDA) issued a critical warning to health care professionals about the risks ...

Any family history of BPI should also be noted. [19] Any examination dependent on neurological or motor function must be interpreted in the context of the infant's gestational age, underlying ...

Recently in 2024, the agency received a report involving a patient who received the nasal solution as an injection.